The pathological diagnosis of diffuse gliomas: Towards a smart synthesis of microscopic and molecular information in a multidisciplinary context

Diagnostic Histopathology

Volumn 17, Issue 11, 2011, Pages 486-494

  Wesseling, Pieter ^a   Kros, Johan M ^b   Jeuken, Judith W M ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Astrocytoma; Glioblastoma; Glioma; Histopathology; Molecular diagnostics; Oligodendroglioma

Indexed keywords

ARTICLE; ASTROCYTOMA; CHROMOSOME LOSS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; MOLECULAR DIAGNOSIS; NEUROIMAGING; OLIGODENDROGLIOMA; PROGNOSIS; TUMOR CLASSIFICATION;

EID: 82455175957     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2011.08.005     Document Type: Article

References (20)

1. CBTRUS; Central Brain Tumor Registry of the United States 2010. http://www.cbtrus.org.
2. WHO classification of tumours of the central nervous system 2007, IARC Press, Lyon. 3rd edn. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee (Eds.).
3. Burger P C, Scheithauer B W. Tumors of the central nervous system; AFIP Atlas of tumor pathology, 4th series, vol. 7; 2007.
4. Perry A., Brat D.J. Practical surgical neuropathology 2010, Churchill Livingstone.
5. Brat D.J., Prayson R.A., Ryken T.C., Olson J.J. Diagnosis of malignant glioma: role of neuropathology. J Neurooncol 2008, 89:287-311.
6. Dunbar E., Yachnis A.T. Glioma diagnosis: immunohistochemistry and beyond. Adv Anat Pathol 2010, 17:187-201.
7. Burger P.C. Smears and frozen sections in surgical neuropathology: a manual 2009, PB Medical Publishing LLC.
8. Riemenschneider M.J., Jeuken J.W., Wesseling P., Reifenberger G. Molecular diagnostics of gliomas: state of the art. Acta Neuropathol 2010, 120:567-584.
9. Claes A., Idema A.J., Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007, 114:443-458.
10. Plesec T.P., Prayson R.A. Frozen section discrepancy in the evaluation of central nervous system tumors. Arch Pathol Lab Med 2007, 131:1532-1540.
11. Powell S.Z. Intraoperative consultation, cytologic preparations, and frozen section in the central nervous system. Arch Pathol Lab Med 2005, 129:1635-1652.
12. Kros J.M., Gorlia T., Kouwenhoven M.C., et al. Panel review of anaplastic oligodendroglioma from European Organization for Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol 2007, 66:545-551.
13. van den Bent M.J. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective. Acta Neuropathol 2010, 120:297-304.
14. Ohgaki H., Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007, 170:1445-1453.
15. TCGA; The Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
16. Jeuken J.W.M., Sijben A., Bleeker F.E., et al. The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas; further elucidation of their genetic 'life story'. Brain Pathol 2011, 21:308-320.
17. Tabatabai G., Stupp R., van den Bent M.J., et al. Molecular diagnostics of gliomas: the clinical perspective. Acta Neuropathol 2010, 120:585-592.
18. Parsons D.W., Jones S., Zhang X., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
19. Weller M., Stupp R., Reifenberger G., et al. MGMT promoter methylation in malignant gliomas: ready for personalized medicine?. Nat Rev Neurol 2010, 6:39-51.
20. Wen P.Y., Macdonald D.R., Reardon D.A., et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010, 28:1963-1972.